A detailed history of Ameriprise Financial Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 4,525,434 shares of EXAS stock, worth $230 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,525,434
Previous 2,214,730 104.33%
Holding current value
$230 Million
Previous $93.6 Million 229.3%
% of portfolio
0.08%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $98 Million - $164 Million
2,310,704 Added 104.33%
4,525,434 $308 Million
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $1.87 Million - $3.36 Million
-45,252 Reduced 2.0%
2,214,730 $93.6 Million
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $12.5 Million - $16.4 Million
-221,922 Reduced 8.94%
2,259,982 $156 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $44.8 Million - $57.4 Million
-757,744 Reduced 23.39%
2,481,904 $184 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $38.5 Million - $57.9 Million
-584,178 Reduced 15.28%
3,239,648 $221 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $29.1 Million - $44.2 Million
-464,499 Reduced 10.83%
3,823,826 $359 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $19.5 Million - $29.2 Million
412,998 Added 10.66%
4,288,325 $291 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $6 Million - $10.5 Million
197,740 Added 5.38%
3,875,327 $192 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $6.36 Million - $9.82 Million
198,805 Added 5.71%
3,677,587 $119 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $25.2 Million - $54 Million
707,851 Added 25.55%
3,478,782 $137 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $57.7 Million - $82.7 Million
-1,002,095 Reduced 26.56%
2,770,931 $194 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $29.3 Million - $40.7 Million
404,721 Added 12.02%
3,773,026 $294 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $18 Million - $24.8 Million
199,792 Added 6.31%
3,368,305 $322 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $5.09 Million - $7.57 Million
-54,362 Reduced 1.69%
3,168,513 $394 Million
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $37.4 Million - $49.7 Million
-320,668 Reduced 9.05%
3,222,875 $425 Million
Q4 2020

Feb 12, 2021

SELL
$99.61 - $142.12 $21.1 Million - $30.1 Million
-211,917 Reduced 5.64%
3,543,543 $470 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $27.3 Million - $38.2 Million
-374,624 Reduced 9.07%
3,755,460 $383 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $41.9 Million - $69.8 Million
752,408 Added 22.28%
4,130,084 $359 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $7.24 Million - $20 Million
191,035 Added 5.99%
3,377,676 $196 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $15.1 Million - $19.4 Million
194,117 Added 6.49%
3,186,641 $295 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $34.4 Million - $46.7 Million
-380,912 Reduced 11.29%
2,992,524 $271 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $82 Million - $108 Million
-915,597 Reduced 21.35%
3,373,436 $398 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $1.68 Million - $2.62 Million
-27,156 Reduced 0.63%
4,289,033 $371 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $99.2 Million - $146 Million
1,770,503 Added 69.55%
4,316,189 $272 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $121 Million - $201 Million
2,499,633 Added 5427.73%
2,545,686 $201 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $1.06 Million - $1.96 Million
-27,967 Reduced 37.78%
46,053 $2.78 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $1.77 Million - $2.56 Million
-44,507 Reduced 37.55%
74,020 $2.98 Million
Q4 2017

Feb 12, 2018

SELL
$46.49 - $60.51 $3.33 Million - $4.34 Million
-71,724 Reduced 37.7%
118,527 $6.22 Million
Q3 2017

Nov 07, 2017

BUY
$37.05 - $47.12 $7.05 Million - $8.96 Million
190,251
190,251 $8.97 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.01B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.